All Research News articles – Page 4
-
NewsLower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen
A dose-sparing intradermal mpox vaccination regimen was safe and generated an antibody response equivalent to that induced by the standard regimen at six weeks (two weeks after the second dose), according to new findings.
-
NewsReview probes gel formation mechanisms and the role of lactic acid bacteria in fermented sausage
Researchers have reviewed the process of gel formation in fermented sausages, emphasizing the crucial role of myofibrillar proteins and the influence of lactic acid bacteria, temperature, and processing methods on gel properties.
-
NewsThe rise of microbial cheaters in iron-limited environments
Competition and cooperation are fundamental forces that govern the evolutionary and ecological dynamics among species. The balance between these forces varies across ecological contexts, with some environments favoring cooperative behaviors that promote mutual benefit, while others reward competitive strategies that maximize individual fitness. Among microbial communities, chemicals ...
-
NewsStudy confirms effectiveness of bivalent COVID-19 vaccine
A major bivalent COVID-19 vaccine induces production of neutralizing antibodies against the coronavirus that circulated at the start of the pandemic as well as subvariants of omicron, albeit less abundantly, according to a new study.
-
NewsTreatment for deadly superbug C. diff may be weakening
The antibiotic vancomycin, recommended as first-line treatment for infection caused by the deadly superbug C. difficile (C. diff), may not be living up to its promise, according to new research.
-
NewsScientists deploy synthetic amyloids to figure out ways of targeting biofilms
New research being presented at the Letters in Applied Microbiology ECS Research Symposium this May will reveal how scientists are investigating how macrophages can be used to break down amyloid plaques in biofilms.
-
NewsCocktails of antibiotics, probiotics and prebiotics hold promise in treating a common form of irritable bowel syndrome
Personalised “cocktails” of antibiotics, probiotics and prebiotics hold great promise in the treatment of a common form of irritable bowel syndrome (IBS), a new study suggests.
-
NewsCRISPR is promising to tackle antimicrobial resistance - but remember bacteria can fight back
Experts are looking to use the Nobel winning technology to target resistance genes and make bacteria sensitive to first line antibiotics again; but the bacteria have ways to fight back.
-
NewsAntibiotic use in patients hospitalised with COVID-19 appears to have no beneficial effect on clinical outcomes
An analysis of more than 1,300 German adults hospitalised with moderate COVID-19 finds treatment with antibiotics was associated with five times greater likelihood of COVID-19 deterioration compared to patients not given antibiotics.
-
News Antimicrobial-resistant hospital infections remain at least 12% above pre-pandemic levels, major US study finds
Despite progress in combating antimicrobial resistance (AMR) in the USA since its peak during the COVID-19 pandemic, hospital-acquired AMR infections remain well above pre-pandemic levels, according to a major new study examining AMR before, during, and after the COVID-19 pandemic in 120 US hospitals. Source: NIAID Colorized scanning ...
-
NewsBarley plants fine-tune their root microbial communities through sugary secretions
Different types of barley recruit distinct communities of soil microbes to grow around their roots by releasing a custom mix of sugars and other compounds, according to a new study.
-
NewsClimate change linked surge in malaria transmission could be less than feared
Despite concerns about the potential impact of climate change on increasing malaria risk, there is still limited understanding of how temperature affects malaria transmission – until now.
-
NewsMicrobiota enterotoxigenic Bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance
A new study highlights the importance of considering the microbiome as a factor in cancer treatment and offers a promising avenue for developing novel therapeutic strategies aimed at enhancing efficacy of breast cancer treatments.
-
NewsPaclitaxel-induced immune dysfunction and activation of transcription factor AP-1 facilitate Hepatitis B virus replication
A study finds that Paclitaxel treatment directly promotes HBV replication and transcription, leading to HBV reactivation in HBV stable expression cell models, HBV natural infection cell models, and HBV transgenic mouse models.
-
NewsTo mask or not to mask? Understanding public health behaviors during COVID-19
Researchers from Osaka University find that mask-wearing behavior depends on complex relationships between context and social norms.
-
NewsScientists graft Prunus sp. to control crown gall disease by regulating the rhizosphere environment
This study provides insights into the mechanism whereby grafted Prunus plants make use of root exudates and the rhizosphere microbiome to suppress soil-borne crown gall disease.
-
NewsUndiscovered diversity of Micropsalliota: Seven new species and one newly recorded species in southern China
Multi-gene phylogeny and morphological characters reveal seven new species of Micropsalliota (Agaricales, Agaricaceae) from southern China, with an updated key for the species distributed in China.
-
NewsMosquito-borne diseases become a global phenomenon in a warmer, more populated world
An additional 4.7 billion people around the world are predicted to be at risk of malaria and dengue by 2100 if emissions and population growth continue to rise at current levels.
-
NewsClimate change is multiplying the threat caused by antimicrobial resistance
Climate change is multiplying the threat caused by antimicrobial resistance (AMR), amplifying its growing risk through increasing global temperatures, greenhouse gas emissions and rising sea levels, experts have warned.
-
NewsNew ultraviolet light air disinfection technology could help protect against healthcare infections and even the next pandemic
Low doses of a particular wavelength of ultraviolet light, known as far-UVC, can kill viruses and bacteria without the safety concerns of conventional ultraviolet light.
